⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LENZ News
LENZ Therapeutics, Inc. Common Stock
GTC 2026 Live: This "Breathing" Glass Rack Reveals the Physical Form of Next-Gen AI Compute as an Intelligent Lifeform
prnewswire.com
NVDA
LENZ
LENZ Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights on March 24, 2026
globenewswire.com
LENZ
LENZ Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights on March 24, 2026
globenewswire.com
LENZ
LENZ Therapeutics Announces Submission of Marketing Authorization Application to European Medicines Agency for VIZZ® for the Treatment of Presbyopia
globenewswire.com
LENZ
LENZ Therapeutics Announces Submission of Marketing Authorization Application to European Medicines Agency for VIZZ® for the Treatment of Presbyopia
globenewswire.com
LENZ
LENZ Therapeutics to Present at Upcoming Investor Conferences
globenewswire.com
LENZ
Trax Limited Divests Image Recognition Business to Gemspring Capital; Remaining Trax Ltd. Businesses Poised for Focused Growth and Market Expansion
prnewswire.com
LENZ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LENZ Therapeutics, Inc. - LENZ
accessnewswire.com
LENZ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LENZ Therapeutics, Inc. - LENZ
accessnewswire.com
LENZ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LENZ Therapeutics, Inc. - LENZ
accessnewswire.com
LENZ